Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2001 Sep;71(3):347–351. doi: 10.1136/jnnp.71.3.347

A new nephelometric assay for β-trace protein (prostaglandin D synthase) as an indicator of liquorrhoea

H Petereit 1, G Bachmann 1, M Nekic 1, H Althaus 1, R Pukrop 1
PMCID: PMC1737575  PMID: 11511708

Abstract

OBJECTIVES—To determine the sensitivity and specificity of a nephelometric β-trace protein assay for the diagnosis of liquorrhoea.
METHODS—One hundred and forty clinical samples with suspected liquorrhoea were analysed by a newly developed nephelometric assay. An established electroimmunoassay served as a reference method. The sensitivity and specificity of the β-trace nephelometric assay were calculated by a 2x2 contingency table for 10 different versions of a dichotomised nephelometric variable. In 52 patients (79 samples), the nephelometric findings were validated by referring to the clinical diagnosis based on the course of the disease, imaging techniques, and surgical inspection.
RESULTS—Given a specificity of 100%, a β-trace protein concentration of 6 mg/l or higher in a sample indicated liquorrhoea with a sensitivity of 92% compared with the reference method and of 93% compared with the clinical evaluation. The relation between the electroimmunoassay and the nephelometric assay was highly significant (p<0.001).
CONCLUSIONS—The nephelometric β-trace protein assay is a simple and rapid method for the detection of liquorrhoea with high sensitivity and specificity and may facilitate the diagnosis of fistulas leaking CSF.



Full Text

The Full Text of this article is available as a PDF (147.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachmann G., Achtelik R., Nekic M., Michel O. Beta-trace-Protein in der Diagnostik der Liquorfistel. HNO. 2000 Jul;48(7):496–500. doi: 10.1007/s001060050605. [DOI] [PubMed] [Google Scholar]
  2. Barlas O., Bayindir C., Hepgül K., Can M., Kiriş T., Sencer E., Unal F., Aral F. Bromocriptine-induced cerebrospinal fluid fistula in patients with macroprolactinomas: report of three cases and a review of the literature. Surg Neurol. 1994 Jun;41(6):486–489. doi: 10.1016/0090-3019(94)90013-2. [DOI] [PubMed] [Google Scholar]
  3. Blödorn B., Brück W., Tumani H., Michel U., Rieckmann P., Althans N., Mäder M. Expression of the beta-trace protein in human pachymeninx as revealed by in situ hybridization and immunocytochemistry. J Neurosci Res. 1999 Sep 1;57(5):730–734. [PubMed] [Google Scholar]
  4. Blödorn B., Mäder M., Urade Y., Hayaishi O., Felgenhauer K., Brück W. Choroid plexus: the major site of mRNA expression for the beta-trace protein (prostaglandin D synthase) in human brain. Neurosci Lett. 1996 May 10;209(2):117–120. doi: 10.1016/0304-3940(96)12614-8. [DOI] [PubMed] [Google Scholar]
  5. Brodie H. A., Thompson T. C. Management of complications from 820 temporal bone fractures. Am J Otol. 1997 Mar;18(2):188–197. [PubMed] [Google Scholar]
  6. Byrne J. V., Ingram C. E., MacVicar D., Sullivan F. M., Uttley D. Digital subtraction cisternography: a new approach to fistula localisation in cerebrospinal fluid rhinorrhoea. J Neurol Neurosurg Psychiatry. 1990 Dec;53(12):1072–1075. doi: 10.1136/jnnp.53.12.1072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clark D., Bullock P., Hui T., Firth J. Benign intracranial hypertension: a cause of CSF rhinorrhoea. J Neurol Neurosurg Psychiatry. 1994 Jul;57(7):847–849. doi: 10.1136/jnnp.57.7.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Durand M. L., Calderwood S. B., Weber D. J., Miller S. I., Southwick F. S., Caviness V. S., Jr, Swartz M. N. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993 Jan 7;328(1):21–28. doi: 10.1056/NEJM199301073280104. [DOI] [PubMed] [Google Scholar]
  9. Eguchi N., Minami T., Shirafuji N., Kanaoka Y., Tanaka T., Nagata A., Yoshida N., Urade Y., Ito S., Hayaishi O. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):726–730. doi: 10.1073/pnas.96.2.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Felgenhauer K., Schädlich H. J., Nekic M. Beta trace-protein as marker for cerebrospinal fluid fistula. Klin Wochenschr. 1987 Aug 17;65(16):764–768. doi: 10.1007/BF01743251. [DOI] [PubMed] [Google Scholar]
  11. Giacomelli S., Leone M. G., Grima J., Silvestrini B., Cheng C. Y. Astrocytes synthesize and secrete prostaglandin D synthetase in vitro. Biochim Biophys Acta. 1996 Feb 29;1310(3):269–276. doi: 10.1016/0167-4889(95)00182-4. [DOI] [PubMed] [Google Scholar]
  12. Graham J. M., Phelps P. D., Michaels L. Congenital malformations of the ear and cochlear implantation in children: review and temporal bone report of common cavity. J Laryngol Otol Suppl. 2000;25:1–14. doi: 10.1258/0022215001904842. [DOI] [PubMed] [Google Scholar]
  13. Grünewald S., Huyben K., de Jong J. G., Smeitink J. A., Rubio E., Boers G. H., Conradt H. S., Wendel U., Wevers R. A. beta-Trace protein in human cerebrospinal fluid: a diagnostic marker for N-glycosylation defects in brain. Biochim Biophys Acta. 1999 Sep 20;1455(1):54–60. doi: 10.1016/s0925-4439(99)00078-2. [DOI] [PubMed] [Google Scholar]
  14. Hoffmann A., Conradt H. S., Gross G., Nimtz M., Lottspeich F., Wurster U. Purification and chemical characterization of beta-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase. J Neurochem. 1993 Aug;61(2):451–456. doi: 10.1111/j.1471-4159.1993.tb02145.x. [DOI] [PubMed] [Google Scholar]
  15. Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
  16. Mase M., Yamada K., Iwata A., Matsumoto T., Seiki K., Oda H., Urade Y. Acute and transient increase of lipocalin-type prostaglandin D synthase (beta-trace) level in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage. Neurosci Lett. 1999 Aug 6;270(3):188–190. doi: 10.1016/s0304-3940(99)00494-2. [DOI] [PubMed] [Google Scholar]
  17. Melegos D. N., Freedman M. S., Diamandis E. P. Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders. Prostaglandins. 1997 Jul;54(1):463–474. doi: 10.1016/s0090-6980(97)00062-2. [DOI] [PubMed] [Google Scholar]
  18. Melegos D. N., Grass L., Pierratos A., Diamandis E. P. Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure. Urology. 1999 Jan;53(1):32–37. doi: 10.1016/s0090-4295(98)00453-1. [DOI] [PubMed] [Google Scholar]
  19. Normansell D. E., Stacy E. K., Booker C. F., Butler T. Z. Detection of beta-2 transferrin in otorrhea and rhinorrhea in a routine clinical laboratory setting. Clin Diagn Lab Immunol. 1994 Jan;1(1):68–70. doi: 10.1128/cdli.1.1.68-70.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Oberascher G., Arrer E. Immunologische Liquordiagnostik mittels beta 2-Transferrin-Grundlagen und Methodik. Laryngol Rhinol Otol (Stuttg) 1986 Mar;65(3):158–161. [PubMed] [Google Scholar]
  21. Olry R., Fischer A. The limbic terminology: natural history of semantic fluctuations. Acta Belg Hist Med. 1993 Dec;6(4):220–223. [PubMed] [Google Scholar]
  22. Olry R., Haines D. E. Cerebral mythology: a skull stuffed with gods. (Neurowords 3) Hist Neurosci. 1998 Apr;7(1):82–83. doi: 10.1076/jhin.7.1.82.13104. [DOI] [PubMed] [Google Scholar]
  23. Ramsden J. D., Corbridge R., Bates G. Bilateral cerebrospinal fluid rhinorrhoea. J Laryngol Otol. 2000 Feb;114(2):137–138. doi: 10.1258/0022215001904897. [DOI] [PubMed] [Google Scholar]
  24. Saso L., Leone M. G., Sorrentino C., Giacomelli S., Silvestrini B., Grima J., Li J. C., Samy E., Mruk D., Cheng C. Y. Quantification of prostaglandin D synthetase in cerebrospinal fluid: a potential marker for brain tumor. Biochem Mol Biol Int. 1998 Nov;46(4):643–656. doi: 10.1080/15216549800204172. [DOI] [PubMed] [Google Scholar]
  25. Skedros D. G., Cass S. P., Hirsch B. E., Kelly R. H. Beta-2 transferrin assay in clinical management of cerebral spinal fluid and perilymphatic fluid leaks. J Otolaryngol. 1993 Oct;22(5):341–344. [PubMed] [Google Scholar]
  26. Sloman A. J., Kelly R. H. Transferrin allelic variants may cause false positives in the detection of cerebrospinal fluid fistulae. Clin Chem. 1993 Jul;39(7):1444–1445. [PubMed] [Google Scholar]
  27. Thalmann I., Kohut R. I., Ryu J., Comegys T. H., Senarita M., Thalmann R. Protein profile of human perilymph: in search of markers for the diagnosis of perilymph fistula and other inner ear disease. Otolaryngol Head Neck Surg. 1994 Sep;111(3 Pt 1):273–280. doi: 10.1177/01945998941113P117. [DOI] [PubMed] [Google Scholar]
  28. Tumani H., Nau R., Felgenhauer K. Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann Neurol. 1998 Dec;44(6):882–889. doi: 10.1002/ana.410440606. [DOI] [PubMed] [Google Scholar]
  29. Urade Y., Hayaishi O. Prostaglandin D2 and sleep regulation. Biochim Biophys Acta. 1999 Jan 4;1436(3):606–615. doi: 10.1016/s0005-2760(98)00163-5. [DOI] [PubMed] [Google Scholar]
  30. Xenos C., Rosenfeld J. V., Kleid S. M. Intracranial extension of sphenoid sinusitis. Head Neck. 1995 Jul-Aug;17(4):346–350. doi: 10.1002/hed.2880170413. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES